Could This Recent IPO Biotech Become the Next Moderna?

Pliant Therapeutics (NASDAQ:PLRX) held a successful IPO earlier this month, raising $144 million after originally planning to raise $86 million. While that upsized amount paled in comparison to Moderna's $604 million IPO, the question still lingers: Could Pliant become the next Moderna?